Radiofrequency Ablation for the Palliative Treatment of Bone Metastases: A Multidisciplinary Discussion
Outcomes in the first 100 patients in the OPuS One Clinical Study were recently published in the JVIR November edition. View the publication – medtronic.com/opusone.
A multidisciplinary panel presents a high-level overview of the OPuS One Post-Market Clinical Study evaluating the effectiveness of the OsteoCool™ Radiofrequency Ablation System, dives deeper into the latest data released on 100 patients treated, and discusses the benefits of taking a multidisciplinary approach to treating patients with metastatic bone disease. For more information on the OPuS One Study, please visit medtronic.com/opusone.
Comments 0
Login to view comments.
Click here to Login
